Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Chronic Kidney Disease
52%
Odds Ratio
43%
Glomerular Filtration Rate
39%
Hemodialysis
36%
Cardiovascular System
36%
C Reactive Protein
27%
COVID-19
26%
Proteinuria
26%
Hazard Ratio
26%
Cardiovascular Disease
24%
Creatinine
23%
Acute Coronary Syndrome
23%
Prospective Cohort Study
21%
Myocardial Infarction
20%
All Cause Mortality
19%
Contrast-Induced Nephropathy
19%
Kidney Function
18%
Cardiovascular Risk
17%
Adiponectin
17%
Pitavastatin
17%
ST Segment Elevation Myocardial Infarction
17%
Bleeding
17%
Nephropathy
15%
Heart Failure
15%
Primary Percutaneous Coronary Intervention
14%
Cohort Analysis
14%
Neutrophil Cytoplasmic Antibody
13%
Coronary Artery Calcification
13%
Prevalence
12%
Saphenous Vein Graft
12%
Proportional Hazards Model
12%
Antithrombotic
12%
End Stage Renal Disease
11%
Major Adverse Cardiac Event
11%
Nephrology
11%
Elderly Patient
11%
Intravascular Ultrasound
10%
Coronary Artery Bypass Graft
10%
Serum Albumin
10%
Retrospective Cohort Study
10%
Cardiac Catheterization
10%
Heart Failure with Preserved Ejection Fraction
10%
Adverse Event
9%
Revascularization
9%
Coronary Artery
9%
Rehabilitation Engineering
9%
Exercise
9%
Cross Sectional Study
9%
Infection
9%
Left Coronary Artery
8%
Artery Lesion
8%
Randomized Clinical Trial
8%
Minimal Change Disease
8%
ANCA Associated Vasculitis
8%
Vasculitis
8%
Glomerulonephritis
8%
Adverse Outcome
8%
Proliferin
8%
Population Density
8%
Vitamin K Antagonist
8%
Drug Delivery System
8%
Meta-Analysis
8%
Metabolic Syndrome
8%
Emergency Care
8%
Telerehabilitation
8%
Acute Heart Infarction
8%
SCAN
8%
High Output Cardiac Failure
8%
Semaglutide
8%
Helicobacter Infection
8%
Pylorus
8%
Arachidonic Acid
8%
Percutaneous Aortic Valve Replacement
8%
Target Lesion
8%
Omega-3 Fatty Acid
8%
Omega 6 Fatty Acid
8%
Optical Coherence Tomography
8%
Epidermal Growth Factor Receptor
8%
Stress Echocardiography
8%
In-Stent Restenosis
8%
Screening
8%
Rotational Atherectomy
8%
Atresia
8%
Graves' Disease
8%
Antiplatelet
8%
Rapamycin
8%
Icosapentaenoic Acid
8%
Subgroup Analysis
8%
Heart Muscle Revascularization
8%
Aortic Valve Stenosis
8%
Analeptic
8%
Erythropoietin
8%
Atorvastatin
8%
Glycine Receptor
8%
Heart Rate Variability
8%
Aortic Dissection
8%
Docosapentaenoic Acid
8%
Superficial Femoral Artery
8%
Critical Limb Ischemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
50%
Heart Infarction
36%
Cardiovascular Disease
34%
ST Segment Elevation Myocardial Infarction
33%
C Reactive Protein
27%
Prevalence
26%
Hemodialysis
24%
End Stage Renal Disease
23%
Remission
23%
Infection
22%
Placebo
21%
Cohort Study
21%
All Cause Mortality
21%
Prospective Cohort Study
20%
Pitavastatin
19%
Heart Failure
18%
Proteinuria
17%
Disease
17%
Cardiovascular Risk
17%
ANCA Associated Vasculitis
17%
Adiponectin
17%
Parkinson's Disease
17%
Icosapentaenoic Acid
17%
Omega-3 Fatty Acid
17%
Nicorandil
17%
Serum Albumin
16%
Hospital Mortality
15%
Randomized Clinical Trial
14%
Hyponatremia
14%
Creatinine
13%
Neutrophil Cytoplasmic Antibody
13%
Glomerulonephritis
12%
Atrial Fibrillation
12%
Adverse Event
12%
Drug Delivery System
11%
Major Adverse Cardiac Event
11%
Syndrome
11%
Statin (Protein)
10%
Cardiovascular Mortality
10%
Randomized Controlled Trial
10%
Bleeding
10%
Observational Study
10%
Inflammation
10%
Combination Therapy
8%
Tissue Inhibitor of Metalloproteinase 1
8%
Vasculitis
8%
Calcium Antagonist
8%
Adverse Outcome
8%
Proliferin
8%
Metoprolol
8%
Ciclosporin
8%
Antivitamin K
8%
Coronary Artery Atherosclerosis
8%
Ezetimibe
8%
Acetylsalicylic Acid
8%
Rivaroxaban
8%
Lupus Erythematosus Nephritis
8%
Metabolic Syndrome X
8%
Semaglutide
8%
Factor A
8%
Myocardin
8%
Esophagus Cancer
8%
Cross-Sectional Study
8%
Helicobacter Infection
8%
Arachidonic Acid
8%
Omega 6 Fatty Acid
8%
Coronavirinae
8%
Artery Lesion
8%
Peripheral Occlusive Artery Disease
8%
Heart Death
8%
Deterioration
8%
Atorvastatin
8%
Hyperuricemia
8%
Indican
8%
Thiamine Deficiency
8%
Edema
8%
Uric Acid
8%
Myalgia
8%
Congestive Cardiomyopathy
8%
D Dimer
8%
Monotherapy
8%
Dobutamine
8%
Docosapentaenoic Acid
8%
Nitinol
8%
Apixaban
8%
Acute Heart Infarction
8%
Angina Pectoris
8%
Glucocorticoid
8%
Mortality Rate
8%
Neuropathy
6%
Prednisolone
6%
Upacicalcet
5%
Coronary Artery Disease
5%
Diabetes Mellitus
5%
Keyphrases
Confidence Interval
25%
Japan
22%
Prospective Cohort Study
19%
Percutaneous Coronary Intervention
17%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
17%
Japanese Patients
17%
Remission
15%
Odds Ratio
12%
MPO-ANCA
11%
Retrospective Cohort Study
10%
Remission of Proteinuria
8%
Minimal Change Disease
8%
Adult Patients
8%
Early Remission
8%
Serum Albumin Concentration
8%
Activity Participation
8%
Safety Outcomes
8%
Targeted Proteomics
8%
Treatment-related
8%
Outcome Analysis
8%
Vasculitis Damage Index
8%
Elderly Onset
8%
Prednisolone
8%
Overdrive Suppression
8%
Calcium Current
8%
Patients with Hypertension
8%
Institutional Volume
8%
Operator Volume
8%
Calcium Antagonists
8%
Upstream Therapy
8%
Vitamin K Antagonists
8%
Net Clinical Benefit
8%
State-of-the-art Review
8%
Nonagenarians
8%
Stable Cardiovascular Disease
8%
Acute Care Setting
8%
COVID-19
8%
Functional Outcome
8%
Patient Deterioration
8%
Acute Myocardial Infarction
8%
Exercise Capacity
8%
Atrial Fibrillation Detection
8%
High-output Heart Failure
8%
Oral Semaglutide
8%
MRTF-A
8%
Clinical Outcomes
8%
Long-term Clinical Outcome
8%
Percutaneous Coronary Revascularization
8%
Integrated Backscatter Intravascular Ultrasound
8%
Hemodialysis Patients
8%
Non-target
8%
Coronary Artery Bypass Grafting
8%
Ischemic Events
8%
In-stent Restenosis Lesions
8%
Infection Risk
8%
Atresia
8%
Transit-time Flow Measurement
8%
Infection-related Mortality
8%
Incident Dialysis Patients
8%
Parkinson's Disease
8%
Cytoplasmic Antibodies
8%
Hazard Ratio
8%
Serum Uric Acid
8%
Hyperuricemia
8%
Endomyocardial
8%
Dobutamine Stress Echocardiography
8%
Contractile Reserve
8%
Indoxyl Sulfate
8%
Radial Strain
8%
Improve Contrast
8%
Muscle Edema
8%
Long-term Cardiovascular Outcomes
8%
Neutral Sphingomyelinase
8%
Anti-ganglioside Antibodies
8%
GM1 Ganglioside
8%
NSMase2
8%
Membrane-associated
8%
Tertiary Level
8%
Anti-GM1
8%
Sphingomyelin Metabolism
8%
Peripheral Arterial Disease
8%
Long-term Patency
8%
Percutaneous Transluminal Angioplasty
8%
Valve Calcification
8%
Cardiac Valvular Calcification
8%
Incident Hemodialysis Patients
8%
Trousseau Syndrome
8%
Omega-3
8%
Lying Time
8%
Lipid-rich Plaque
8%
Long-term Mortality
8%
Combined Value
8%
Protein Mass
8%
Randomized Controlled Trial
8%
Subgroup Analysis
8%
Cardiovascular Screening
8%
Non-target Lesion
8%
Multicenter Cohort Study
8%
Estimated Glomerular Filtration Rate
8%
Observational Analysis
8%